Copyright
©2014 Baishideng Publishing Group Co.
World J Cardiol. Apr 26, 2014; 6(4): 154-174
Published online Apr 26, 2014. doi: 10.4330/wjc.v6.i4.154
Published online Apr 26, 2014. doi: 10.4330/wjc.v6.i4.154
Structural alterations | |
Major | TTE regional RV akinesia, dyskinesia, or aneurysm and 1 of the following criteria (end diastole) |
PLAX RVOT ≥ 32 mm [(PLAX/BSA) ≥ 19 mm/m2] | |
PSAX RVOT ≥ 36 mm [(PSAX/BSA) ≥ 21 mm/m2] | |
Or RV fractional area change ≤ 33% | |
CMR regional RV akinesia, dyskinesia, or dyssynchronous RV contraction and 1 of the following criteria (end diastole) | |
RV end-diastolic volume/BSA ≥ 110 mL/m2 (♂) or ≥ 100 mL/m2 (♀) | |
Or RV ejection fraction ≤ 40% | |
RV angiography regional RV akinesia, dyskinesia, or aneurysm | |
Minor | TTE regional RV akinesia, or dyskinesia and 1 of the following criteria (end diastole) |
PLAX RVOT ≥ 29-31mm [(PLAX/BSA) ≥ 16-18 mm/m2] | |
PSAX RVOT ≥ 32-35 mm [(PSAX/BSA) ≥ 18-20 mm/m2] | |
RV fractional area change > 33%-39% | |
CMR regional RV akinesia, dyskinesia, or dyssynchronous RV contraction and 1 of the following criteria (end diastolic) | |
RV end-diastolic volume/BSA ≥ 100-109 mL/m2 (♂) or ≥ 90-99 mL/m2 (♀) | |
Or RV ejection fraction > 40%-44% | |
Histopathology (endomyocardial biopsy) | |
Major | Residual myocytes < 60% by morphometric analysis with fibrous replacement of the RV free wall myocardium ≥ 1 sample, with or without fatty replacement |
Minor | Residual myocytes 60%-75% by morphometric analysis with fibrous |
Replacement of the RV free wall ≥ 1 sample | |
Repolarization abnormalities (> 14 years of age) | |
Major | T-wave inversions V1-V3 or beyond (in absence of complete RBBB) |
Minor | T-wave inversions V1-V2 or V4-V6 (in absence of complete RBBB) |
T-wave inversions V1-V4, if complete RBBB present | |
Depolarization abnormalities | |
Major | Epsilon wave (reproducible low-amplitude signals between end of QRS complex to onset of the T-wave) in V1 to V3 |
Minor | SAECG with late potentials (if QRS complex on standard surface ECG < 110 ms) or terminal activation duration of QRS ≥ 55 ms in V1, V2 or V3 |
Arrhythmias | |
Major | VT of LBBB morphology with superior axis |
Minor | VT of RVOT configuration, LBBB morphology with inferior axis or of unknown axis |
> 500 PVC per 24 h (holter) | |
Family history | |
Major | ARVC/D in a first-degree relative who meets current TFC |
ARVC/D confirmed pathologically at autopsy or surgery in a first-degree relative | |
Identification of a pathogenic mutation categorized associated with ARVC/D in an index patient | |
Minor | Suspected ARVC/D in a first-degree relative-premature SCD (< 35 years of age) due to suspected ARVC/D in a first-degree relative |
ARVC/D confirmed pathologically or by current TFC in second-degree relatives |
- Citation: Saguner AM, Brunckhorst C, Duru F. Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease. World J Cardiol 2014; 6(4): 154-174
- URL: https://www.wjgnet.com/1949-8462/full/v6/i4/154.htm
- DOI: https://dx.doi.org/10.4330/wjc.v6.i4.154